Ó³»­´«Ã½

Kimberly Stegmaier is an institute member of the Ó³»­´«Ã½, where she is also a member of the Cancer Program Scientific Advisory Committee. Stegmaier is a physician-scientist and chair of the Department of Pediatric Oncology at Dana-Farber Cancer Institute, associate chief of the Division of Hematology/Oncology at Boston Children’s Hospital, and the David G. Nathan Professor of Pediatrics at Harvard Medical School. She has been a faculty member at Dana-Farber Cancer Institute, Boston Children’s Hospital, and Harvard Medical School since 2002 and an independent investigator since 2006. Stegmaier is dedicated to the goal of precision pediatric oncology medicine, pioneering the development and application of innovative genomic approaches to identify new therapies for childhood cancer. She has focused her research efforts on acute leukemias and pediatric solid tumors of childhood, particularly those driven by fusion oncoproteins. Her lab has discovered novel technologies, concepts, and targets with translational impact.

Stegmaier was appointed by President Biden to the National Cancer Advisory Board and recently served on the board of directors of the American Association for Cancer Research (AACR). She is the former chair of the St. Jude Children’s Research Hospital Scientific Advisory Board and the AACR Pediatric Cancer Working Group. She is the recipient of numerous awards, such as the Joanne Levy, MD, Memorial Award for Outstanding Achievement from the American Society of Hematology, a Stand Up To Cancer (SU2C) Innovative Research Grant, an E. Mead Johnson Award for Research in Pediatrics, and NCI Outstanding Investigator R35 Awards. She was elected to the American Society of Clinical Investigation and the Association of American Physicians. Her deep commitment to training the next generation of researchers has been recognized with the A. Clifford Barger Excellence in Mentoring Award from Harvard Medical School and the Casty Family Achievement in Mentoring Award from the Dana-Farber Cancer Institute.

Stegmaier received her undergraduate degree from Duke University, medical degree from Harvard Medical School, and trained in pediatrics and pediatric hematology/oncology at Boston Children’s Hospital and Dana-Farber Cancer Institute.